Low Voltage-Directed Catheter Ablation for Atrial Fibrillation

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
Ohad Ziv
Study ID
NCT03355456
Status
Recruiting

Conditions

  • Atrial Fibrillation - Symptomatic

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Radiofrequency ablation — PROCEDURE
    Ablation procedure to eliminate atrial fibrillation

Study Details

A two-pronged approach to evaluate long term success of non-paroxysmal ablation when using a: 1. specified low voltage-directed with pulmonary vein isolation (LD+PVI) approach compared to , 2. an approach of pulmonary vein isolation (PVI) alone.

Key Dates

Start date
Jul 14, 2019
Status verified
Jun 2024
Primary completion
May 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
250 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Pulmonary vein isolation (PVI) alone
    Radiofrequency ablation procedure to isolate pulmonary veins without other intervention performed..
  • Active Comparator: PVI+Total LT Atrial low voltage ablation
    PVI radiofrequency ablation along with ablation of areas of "low voltage" identified.

Primary Outcome Measure

Freedom from first arrhythmia recurrence defined as sustained symptomatic or asymptomatic atrial fibrillation, atrial flutter or atrial tachycardia. [ Time Frame: Any event between the 3 month blanking period and 1 year post-ablation. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MetroHealth Medical CenterClevelandOhio44109
Peter Leo BS, RN
216-778-2714

Find similar trials in Cleveland, OH